Role of Fetal Sex in the Outcome of Antenatal Glucocorticoid Treatment to Prevent Respiratory Distress Syndrome: Systematic Review and Meta-Analysis

Journal of Obstetrics and Gynaecology Canada

Volumn 33, Issue 3, 2011, Pages 216-226

  Roberge, Stéphanie ^a,b   Lacasse, Yves ^c   Tapp, Sylvie ^b   Tremblay, Yves ^a,b   Kari, Anneli ^d   Liu, Jing ^e   Fekih, Myriam ^f   Qublan, Hussein S ^g   Amorim, Melania M ^h   Bujold, Emmanuel ^a,b  

^a UNIVERSITÉ LAVAL   (Canada)

^b LAVAL UNIVERSITY   (Canada)

^c LAVAL UNIVERSITY   (Canada)

^d UNIVERSITY OF HELSINKI   (Finland)

^e CHINESE PLA GENERAL HOSPITAL   (China)

^f UNIVERSITY OF SOUSSE   (Tunisia)

^g KING HUSSEIN MEDICAL CENTER   (Jordan)

^h FEDERAL UNIVERSITY OF CAMPINA GRANDE   (Brazil)

Author keywords

Antenatal glucocorticoids; Fetal sex; Respiratory distress syndrome

Indexed keywords

BETAMETHASONE; DEXAMETHASONE; GLUCOCORTICOID;

ARTICLE; BRAIN HEMORRHAGE; HUMAN; META ANALYSIS; NEONATAL RESPIRATORY DISTRESS SYNDROME; NEWBORN MORTALITY; OUTCOME ASSESSMENT; PRENATAL PERIOD; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK FACTOR; RISK REDUCTION; SEX DIFFERENCE; SEX ROLE; SYSTEMATIC REVIEW; FEMALE; FETAL THERAPY; MALE; NEWBORN; PREGNANCY; PREMATURITY; REVIEW;

FEMALE; FETAL THERAPIES; GLUCOCORTICOIDS; HUMANS; INFANT, NEWBORN; MALE; PREGNANCY; PREMATURE BIRTH; RESPIRATORY DISTRESS SYNDROME, NEWBORN; SEX FACTORS;

EID: 79961242724     PISSN: 17012163     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1701-2163(16)34822-8     Document Type: Article

References (39)

1. Norman J., Greer I. Preterm labour managing risk in clinical practice 2005, Cambridge University Press, Cambridge.
2. González R. Prenatal administration of progesterone for preventing preterm birth: RHL commentary. The WHO Reproductive Health Library 2008, World Health Organization, Geneva.
3. Goldenberg R.L., Culhane J.F., Iams J.D., Romero R. Epidemiology and causes of preterm birth. Lancet 2008, 371:75-84.
4. Liggins G.C., Howie R.N. A controlled trial of antepartum glucocorticoid treatment for prevention of the respiratory distress syndrome in premature infants. Pediatrics 1972, 50:515-525.
5. Roberts D., Dalziel S. Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane Database Syst Rev 2006, CD004454.
6. NIH Consensus Development Panel on the Effect of Corticosteroids for Fetal Maturation on Perinatal Outcomes. Effect of corticosteroids for fetal maturation on perinatal outcomes. JAMA 1995, 273:413-418.
7. Elsmen E., Steen M., Hellstrom-Westas L. Sex and gender differences in newborn infants: why are boys at increased risk?. J Mens Health Gend 2004, 1:303-311.
8. Ingemarsson I. Gender aspects of preterm birth. BJOG 2003, 110(Suppl):34-38. 20.
9. Tyson J.E., Parikh N.A., Langer J., Green C., Higgins R.D. Intensive care for extreme prematurity-moving beyond gestational age. N Engl J Med 2008, 358:1672-1681.
10. Lauterbach M.D., Raz S., Sander C.J. Neonatal hypoxic risk in preterm birth infants: the influence of sex and severity of respiratory distress on cognitive recovery. Neuropsychology 2001, 15:411-420.
11. Stevenson D.K., Verter J., FanaroffA.A., Oh W., Ehrenkranz R.A., Shankaran S., et al. Sex differences in outcomes of very low birthweight infants: the newborn male disadvantage. Arch Dis Child Fetal Neonatal Ed 2000, 83:F182-F185.
12. Papageorgiou A.N., Colle E., Farri-Kostopoulos E., Gelfand M.M. Incidence of respiratory distress syndrome following antenatal betamethasone: role of sex, type of delivery, and prolonged rupture of membranes. Pediatrics 1981, 67:614-617.
13. Taeusch H.W., Tulchinsky D. Obstetric factors affecting risk of respiratory distress syndrome. Mead Johnson Symp Perinat Dev Med 1980, 48-55.
14. Ballard P.L., Ballard R.A., Granberg J.P., Sniderman S., Gluckman P.D., Kaplan S.L., et al. Fetal sex and prenatal betamethasone therapy. J Pediatr 1980, 97:451-454.
15. Crowley P.A. Antenatal corticosteroid therapy: a meta-analysis of the randomized trials, 1972 to 1994. Am J Obstet Gynecol 1995, 173:322-335.
16. Moher D., Cook D.J., Eastwood S., Olkin I., Rennie D., Stroup D.F. Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Quality of reporting of meta-analyses. Lancet 1999, 354:1896-1900.
17. Juni P., Altman D.G., Egger M. Systematic reviews in health care: assessing the quality of controlled clinical trials. BMJ 2001, 323:42-46.
18. DerSimonian R., Laird N. Meta-analysis in clin trials. Control Clin Trials 1986, 7:177-188.
19. Higgins J.P., Thompson S.G., Deeks J.J., Altman D.G. Measuring inconsistency in meta-analyses. BMJ 2003, 327:557-560.
20. Egger M., Davey Smith G., Schneider M., Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997, 315:629-634.
21. Sterne J.A., Egger M., Smith G.D. Systematic reviews in health care: Investigating and dealing with publication and other biases in meta-analysis. BMJ 2001, 323:101-105.
22. Egger M., Smith G., Phillips A. Meta-analysis: principles and procedures. BMJ 1997, 315:1533-1537.
23. Effect of antenatal dexamethasone administration on the prevention of respiratory distress syndrome. Am J Obstet Gynecol 1981, 141:276-287.
24. Gamsu H.R., Mullinger B.M., Donnai P., Dash C.H. Antenatal administration of betamethasone to prevent respiratory distress syndrome in preterm infants: report of a UK multicentre trial. Br J Obstet Gynaecol 1989, 96:401-410.
25. Amorim M.M., Santos L.C., Faundes A. Corticosteroid therapy for prevention of respiratory distress syndrome in severe preeclampsia. Am J Obstet Gynecol 1999, 180:1283-1288.
26. Liu J., Wang Q., Zhao J.H., Chen Y.H., Qin G.L. The combined antenatal corticosteroids and vitamin K therapy for preventing periventricular-intraventricular hemorrhage in premature newborns less than 35 weeks gestation. J Trop Pediatr 2006, 52:355-359.
27. Fekih M., Chaieb A., Sboui H., Denguezli W., Hidar S., Khairi H. Value of prenatal corticotherapy in the prevention of hyaline membrane disease in premature infants. Randomized prospective study. [Article in French]. Tunis Med 2002, 80:260-265.
28. Kari M.A., Hallman M., Eronen M., Teramo K., Virtanen M., Koivisto M., et al. Prenatal dexamethasone treatment in conjunction with rescue therapy of human surfactant: a randomized placebo-controlled multicenter study. Pediatrics 1994, 93:730-736.
29. Qublan H.S., Malkawi H.Y., Hiasat M.S., Hindawi I.M., Al-Taani M.I., Abu-Khait S.A., et al. The effect of antenatal corticosteroid therapy on pregnancies complicated by premature rupture of membranes. Clin Exp Obstet Gynecol 2001, 28:183-186.
30. Crowley P., Chalmers I., Keirse M.J. The effects of corticosteroid administration before preterm delivery: an overview of the evidence from controlled trials. Br J Obstet Gynaecol 1990, 97:11-25.
31. Jones H.P., Karuri S., Cronin C.M., Ohlsson A., Peliowski A., Synnes A., et al. Canadian Neonatal Network. Actuarial survival of a large Canadian cohort of preterm infants. BMC Pediatr 2005, 5:40.
32. Clinical obstetrics: the fetus & mother handbook 2007, Blackwell Publishing. 2nd edition. E.A. Reece, J.C. Hobbins, N.F. Gant (Eds.).
33. Baud O., Foix-L'Helias L., Kaminski M., Audibert F., Jarreau P.H., Papiernik E., et al. Antenatal glucocorticoid treatment and cystic periventricular leukomalacia in very premature infants. N Engl J Med 1999, 341:1190-1196.
34. Elimian A. Antenatal betamethasone compared with dexamethasone (betacode trial): a randomized controlled trial. Obstet Gynecol 2007, 110:931.
35. Brownfoot F.C., Crowther C.A., Middleton P. Different corticosteroids and regimens for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane Database Syst Rev 2008, CD006764.
36. Dean F., Matthews S.G. Maternal dexamethasone treatment in late gestation alters glucocorticoid and mineralocorticoid receptor mRNA in the fetal guinea pig brain. Brain Res 1999, 846:253-259.
37. Kovar J., Waddell B.J., Sly P.D., Willet K.E. Sex differences in response to steroids in preterm sheep lungs are not explained by glucocorticoid receptor number or binding affinity. Pediatr Pulmonol 2001, 32:8-13.
38. Matthews S.G. Antenatal glucocorticoids and the developing brain: mechanisms of action. Semin Neonatol 2001, 6:309-317.
39. Ring A.M., Garland J.S., Stafeil B.R., Carr M.H., Peckman G.S., Pircon R.A. The effect of a prolonged time interval between antenatal corticosteroid administration and delivery on outcomes in preterm neonates: a cohort study. Am J Obstet Gynecol 2007, 196:457. e1-e6.